Neurofibroma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) |
Sara Mohsin (talk | contribs) |
||
| Line 12: | Line 12: | ||
* Myxoid [[liposarcoma]] | * Myxoid [[liposarcoma]] | ||
* [[Myxoma]] | * [[Myxoma]] | ||
* Plexiform schwannoma | |||
==References== | ==References== | ||
Revision as of 14:05, 29 March 2019
|
Neurofibroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neurofibroma differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Neurofibroma differential diagnosis |
|
Risk calculators and risk factors for Neurofibroma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2] Shanshan Cen, M.D. [3]
Overview
Neurofibroma must be differentiated from schwannoma, dermatofibrosarcoma protuberans (DFSP), ganglioneuroma, and melanocytic nevus.
Differential Diagnosis
Neurofibroma must be differentiated from:[1]
- Schwannoma
- Dermatofibrosarcoma protuberans (DFSP)
- Ganglioneuroma
- Melanocytic nevus
- Myxoid liposarcoma
- Myxoma
- Plexiform schwannoma
References
- ↑ Neurofibroma. Libre Pathology 2015. http://librepathology.org/wiki/index.php/Neurofibroma#cite_note-pmid15486243-2 Accessed on November 17, 2015